More news from ECTRIMS 2016: Watch presentations and interviews with leading MS experts
Please watch the interesting debate on the question “Do we still have unmet needs in MS therapy” between Gavin Giovannoni and Heinz Wiendl, comparing the ‘old’ immune-modulating therapies with the ‘new’ immunosuppressing treatments.
A new way to distinguish between MS types based on metabolic profiles is proposed by Daniel Anthony from the University of Oxford who is one of the winners of this year’s GMSI award. He talks about biomarker analysis in blood using nuclear magnetic resonance spectroscopy (NMR) as a tool to help remove uncertainty with MS staging.
In an interview taken at ECTRIMS, Prof Fredrikson from the Karolinska University Hospital Huddinge, Stockholm, speaks about the importance of differential diagnosis in MS patients, stating that even in well-established MS clinics there is a 5-10% rate of misdiagnosis.
Joseph R. Berger
Multiple Sclerosis and Related Disorders, Volume 12, February 2017, Pages 59–63
Sex differences in outcomes of disease-modifying treatments for multiple sclerosis: A systematic review
Rui Li, Xiaobo Sun, Yaqing Shu, Zhifeng Mao, Li Xiao, Wei Qiu, Zhengqi Lu, Xueqiang Hu
Multiple Sclerosis and Related Disorders, Volume 12, February 2017, Pages 23–28
The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis
N.L. Fewings, P.N. Gatt, F.C. McKay, G.P. Parnell, S.D. Schibeci, J. Edwards, M.A. Basuki, A. Goldinger, M.J. Fabis-Pedrini, A.G. Kermode, C.P. Manrique, J.L. McCauley, D. Nickles, S.E. Baranzini, T. Burke, S. Vucic, G.J. Stewart, D.R. BoothJournal of Autoimmunity, Volume 78, March 2017, Pages 57–69
Disease progression and oxidative stress are associated with higher serum ferritin levels in patients with multiple sclerosis
Katerine Panichi Zanin Ferreira, Sayonara R Oliveira, Ana Paula Kallaur, Damacio R Kaimen-Maciel, Marcell Alysson B Lozovoy, Elaine Regina Delicato de Almeida, Helena Kaminami Morimoto, Leda Mezzaroba, Isaias Dichi, Edna Maria Vissoci Reiche, Andréa NameJournal of the Neurological Sciences, Volume 373, 15 February 2017, Pages 236–241
Optical coherence tomography: A quantitative tool to measure neurodegeneration and facilitate testing of novel treatments for tissue protection in multiple sclerosis
Eliza Gordon-Lipkin, Peter A. CalabresiJournal of Neuroimmunology, Volume 304, 15 March 2017, Pages 93–96
About the Editors
- Timothy Vartanian, Professor at the Brain and Mind Research Institute and the Department of Neurology, Weill Cornell Medical College, Cornell...
- Claire S. Riley, MD is an assistant attending neurologist and assistant professor of neurology in the Neurological Institute, Columbia University,...
- Rebecca Farber, MD is an attending neurologist and assistant professor of neurology at the Neurological Institute, Columbia University, in New...
- Oct 201723Oct 201728
Progress in Rehabilitation Research (PIRR 2017)Atlanta, United StatesAtlanta, United StatesThe American Congress of Rehabilitation Medicine (ACRM) is dedicated to serving people with disabling conditions. This organisation of rehabilitation professionals...
- Oct 201725Oct 201728Paris, FranceThe joint congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the Americas Committee for...Paris, France
- Nov 201711Nov 201715Washington, DC, United StatesThe annual meeting of the Society for Neuroscience is the premier venue for neuroscientists. It is attended by more than...Washington, DC, United States